Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation
This study is currently recruiting participants.
Verified by Imperial College London, September 2005
First Received: September 5, 2005   Last Updated: April 16, 2007   History of Changes
Sponsors and Collaborators: Imperial College London
Medical Research Council
Information provided by: Imperial College London
ClinicalTrials.gov Identifier: NCT00146952
  Purpose

The investigators propose to explore the hypothesis that vibrotactile channels for indicating spatial orientation can be exploited as a sensory prosthesis. The specific research applications will be used for guiding visual orientation, to provide alternative feedback to vision and vestibular signals for controlling balance, and for directional and lateralisation cueing in patients with neglect syndromes. The programme will study whether vibrotactile feedback improves performance and also if it speeds rehabilitation when used as an adjunct to conventional therapy.


Condition Intervention Phase
Vestibular Diseases
Peripheral Neuropathies
Proprioceptive Disorders
Hemispatial Neglect
Device: Vibrotactile feedback
Phase I

Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label, Active Control, Crossover Assignment, Efficacy Study
Official Title: Evaluation of a Vibrotactile Sensory Aid Developed by the US Navy to Combat Pilot Disorientation as a Prosthesis in Patients With Postural Imbalance and Spatial Disorientation

Resource links provided by NLM:


Further study details as provided by Imperial College London:

Primary Outcome Measures:
  • Mean time reaction to the perturbation with the feedback

Estimated Enrollment: 30
Study Start Date: January 2005
Estimated Study Completion Date: December 2007
  Eligibility

Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Sensory impairments
  • Unsteadiness

Exclusion Criteria:

  • High strokes
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00146952

Contacts
Contact: Michael A Gresty, Pr 020-8846 ext 7634 m.gresty@imperial.ac.uk
Contact: Francois B Asseman, Dr 020-8383 ext 5525 f.asseman@imperial.ac.uk

Locations
United Kingdom
Charing Cross Hospital Recruiting
London, United Kingdom, W6 8RF
Contact: Michael A Gresty, Pr     020-8846 ext 7634     m.gresty@imperial.ac.uk    
Contact: Francois B Asseman, Dr     020-8383 ext 5525     f.asseman@imperial.ac.uk    
Principal Investigator: Michael A Gresty, Pr            
Sub-Investigator: Francois B Asseman, Dr            
Sponsors and Collaborators
Imperial College London
Medical Research Council
Investigators
Principal Investigator: Michael A Gresty, Pr Imperial College London
Study Director: Adolfo M Bronstein, Pr, MD Imperial College London
Study Director: Christopher Kennard, Pr, MD Imperial College London
Study Director: Masud Husain, Dr Imperial College London
  More Information

Additional Information:
No publications provided

Study ID Numbers: DNMCA-PR1077
Study First Received: September 5, 2005
Last Updated: April 16, 2007
ClinicalTrials.gov Identifier: NCT00146952     History of Changes
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by Imperial College London:
Hemineglects

Study placed in the following topic categories:
Sensation Disorders
Signs and Symptoms
Somatosensory Disorders
Otorhinolaryngologic Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Neurologic Manifestations
Confusion
Vestibular Diseases
Ear Diseases
Neurobehavioral Manifestations
Perceptual Disorders

Additional relevant MeSH terms:
Sensation Disorders
Otorhinolaryngologic Diseases
Nervous System Diseases
Confusion
Vestibular Diseases
Ear Diseases
Somatosensory Disorders
Signs and Symptoms
Neuromuscular Diseases
Peripheral Nervous System Diseases
Neurologic Manifestations
Neurobehavioral Manifestations
Perceptual Disorders
Labyrinth Diseases

ClinicalTrials.gov processed this record on September 04, 2009